May 28, 2021Open Access

A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

We found the performance of Molbio's Truenat MTB, MTB Plus and MTB-RIF Dx assays to be comparable to that of the Xpert MTB/RIF assay. Performing the Truenat tests in primary healthcare centres with very limited infrastructure was feasible. These data supported the development of a World Health Organization policy recommendation of the Molbio assays.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Penn‐Nicholson et al. (Fri,) studied this question.

synapsesocial.com/papers/69dbeaf7c34c3c3eb468414a https://doi.org/https://doi.org/10.1183/13993003.00526-2021

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rapid Molecular Detection of Tuberculosis and Rifampin Resistance2010 · 2,306 citations
2Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally2005 · 538 citations
3Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB2014 · 59 citations
4The Role of Clinical Suspicion in Evaluating a New Diagnostic Test for Active Tuberculosis2000 · 149 citations
5Truelab Micro PCR In Diagnosis of Extrapulmonary Tuberculosis: Our Experience2016 · 1 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo